Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS ISSUE:
July 2009

Antipsychotics in Dementia Patients: More Data on Risk
Several studies found a higher risk of adverse events and death in dementia patients prescribed antipsychotics.

DBS: Research Continues
Deep brain stimulation may benefit patients with treatment-resistant depression but carries a risk of serious adverse events.

In Brief
Prenatal Vitamin D Deficiency May Play a Role in Schizophrenia; Depression May Decrease Bone Mineral Density

Ginkgo Biloba: Another Negative Trial in Dementia
In a double-blind trial, Ginkgo biloba did not provide benefit and elevated the risk of stroke in dementia patients.

Comparing Antidepressants
Among new-generation antidepressants, sertraline (Zoloft and others) may be the best first-line medication.

Comparing Antidepressants

July 2009

To receive the imprimatur of the U.S. Food and Drug Administration or the regulatory agencies of other countries, a pharmaceutical compound must be safe and efficacious. However, it is difficult to assess relative efficacy and tolerability among compounds prescribed for the same indication. Antidepressant…

To view the rest of this article, please: